Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation Orphan Drug Tax Credits Amount
Effective Income Tax Rate Reconciliation Orphan Drug Tax Credits Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:EffectiveIncomeTaxRateReconciliationOrphanDrugTaxCreditsAmount.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation orphan drug tax credits amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation orphan drug tax credits amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation orphan drug tax credits amount of -$7.63M in Q4 2025.
- What does effective income tax rate reconciliation orphan drug tax credits amount mean?
- The total tax savings realized from orphan drug development incentives.
- How do you interpret effective income tax rate reconciliation orphan drug tax credits amount?
- Higher values indicate successful development of rare disease therapies and effective capture of specialized tax incentives.
- How does effective income tax rate reconciliation orphan drug tax credits amount compare across companies?
- Specific to biopharmaceutical companies focusing on rare disease pipelines.